Mckesson stock price as of today

As of today, "McKesson stock price" is slightly up by 0.8%, outperforming the broader S&P 500 healthcare sector. Market sentiment is supported by higher prescription volumes and robust oncology drug distribution services. Analysts forecast moderate upside potential if inflation pressures ease. This is a trait that most outlier stocks exhibit…the best of the best. Big Money demand drives stocks upward. Compared to the Zacks Consensus Estimate of $96.08 billion, the reported revenues represent a surprise of +1.82%. The EPS surprise was +0.36%. The latest bullish run in "McKesson stock price" signals investor rotation into defensive healthcare plays. Options activity shows increased call volume at strike prices above $580, suggesting short-term bullish bets.